查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1627585

携带式氧气浓缩机的全球市场：预测（2025-2030）

Portable Oxygen Concentrator Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 141 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计2030年全球携带式氧气浓缩机市场规模将达48.69亿美元，较2025年的28.60亿美元复合年增长率为11.23%。

携带式氧气浓缩机是一种体积小、重量轻、安静的设备，可以持续为患者提供氧气。因此，它可以应用于多种领域，包括家庭护理环境、救护车和航空救护车。携带式氧气浓缩机可确保更高的氧气输出量，也有助于提高重症患者的存活率。

由于世界各地老年人口的不断增长，全球市场对携带式氧气浓缩机的需求正在显着增加，因为它为老年人提供了多种好处，例如预计可以提高他们吸入纯氧的能力。随着人口老化，多种呼吸系统和肺部疾病的风险显着增加，包括慢性阻塞性肺病（COPD）、气喘、肺炎和其他肺部疾病。

数字可能有误：315600000->

世界银行在《世界人口报告》中指出，到2024年，65岁以上人口总数将达到804,475,000人。这与 2021 年相比显着增加，当时 65 岁及以上人口总数为 754,681,000 人，到 2022 年将达到约 778,122,000 人。

携带式氧气浓缩机市场驱动因素

  • 全球呼吸系统疾病患者数量不断增加推动市场扩张

全球肺部和呼吸系统疾病病例数量的增加是预测期内推动全球携带式氧气浓缩机市场成长的关键因素之一。慢性阻塞性肺病、肺气肿和慢性支气管炎等各类呼吸系统和肺部疾病的全球病例在全球范围内显着增长。由于污染、年龄和个人生活方式等多种因素，呼吸道疾病病例显着增加。

美国肺臟协会在报告中指出，美国约有 1,170 万成年人患有 COPD（慢性阻塞性肺病）。同样，美国疾病管制与预防中心美国，到 2023 年，美国总人口中约有 4.3% 将被诊断出患有慢性阻塞性肺病、肺气肿和慢性支气管炎。此外，因气喘等慢性呼吸道疾病死亡的人数为147,382人，即每10万人中有44.2人死亡。肺气肿和支气管炎分别导致 7,905 人和 358 人死亡，而其他慢性呼吸道疾病（不包括气喘）则导致 135,517 人死亡。在日本，因气喘死亡的人数约为3,602人，相当于每10万人中有1.1人死亡。

同样，加拿大统计局在报告中表示，各类呼吸道疾病导致的死亡人数也呈现稳定成长。据该机构称，2021年该国因呼吸系统疾病死亡的人数为311,640人，2022年将上升至334,081人。同样，慢性下呼吸道疾病的死亡人数从2021年的11,018人增加到2022年的12,462人。 2023年，将有12,994人死于慢性呼吸道疾病。

印度呼吸系统疾病患者数量在过去几年也大幅增加。印度市场上肺部和呼吸系统疾病数量增加的主要因素是污染加剧和烟草消费量增加。印度政府国家卫生研究院在报告中指出，印度约25.6%的慢性阻塞性肺病（COPD）病例是由空气污染引起的，其中烟草约占总病例的16.5%。此外，根据《印度公共卫生杂誌》报道，印度慢性阻塞性肺病患者人数估计为3,780万，约占全球慢性阻塞性肺病患者总数的17.8%。该杂誌也指出，全球约27.3%的慢性阻塞性肺病死亡病例是由本国慢性阻塞性肺病患者造成的。

此外，苏格兰公共卫生观察站在其苏格兰公共卫生资讯平台下指出，2018 年至 2023 年间，苏格兰的慢性阻塞性肺病病例将大幅增加。该机构进一步指出，在苏格兰，男性死于慢性阻塞性肺病的总数为 2.2%，而女性死于慢性阻塞性肺病的死亡率为 2.4%。

携带式氧气浓缩机市场的地理前景：

  • 预计北美将在未来几年主导市场

携带式氧气浓缩机是慢性阻塞性肺病和肺癌患者长期氧气疗法的重要组成部分，缩小了氧气溶液的供应和使用之间的差距。对于患有慢性阻塞性肺病和肺癌的患者来说，氧气浓缩机缩小了获得和使用氧气溶液之间的差距，解决这些疾病是美国的主要关注点，并且正在进行各种投资和努力来加强。制定必要的解决方案。

根据肺癌研究基金会的数据，大约 654,620 名美国人将在一生中的某个阶段被诊断出患有肺癌，每年导致 125,070 人死亡。同样，根据美国肺臟协会的《2023 年肺癌状况报告》，到 2023 年，将有近 238,000 人被诊断出患有肺癌，比 2022 年增加 1,000 人。

此外，老年人更容易患呼吸道和肺部疾病，随着美国老年人口的不断增长，被诊断出患有某种类型呼吸道疾病的可能性预计也会增加。根据人口研究所预测，到2050年，65岁以上人口将达到8,200万，比2022年人口增加47%。因此，消息人士进一步指出，老年人口比例将从17%增加到23%。

然而，多年来肺癌治疗的发展已经降低了盛行率，并可能扩大携带式氧气浓缩机的使用。据美国肺癌协会称，过去五年美国的存活率提高了 26%，联邦政府正在藉此机会加强癌症筛检并增加患者获得所需氧气溶液的机会。

此外，领先的携带式氧气浓缩机公司正在进军美国市场，以优化不断成长的商机。例如，根据Inogen Inc.的2023年年报，该公司3.156亿美元的收益中，美国贡献了2.263亿美元，占总收益的近70%。

此外，该公司还投资于新产品的发布，最近的进展包括于 2024 年 10 月在美国市场推出适合家庭护理的 Rove 4携带式氧气浓缩机。在不断努力降低肺癌患者死亡率之后，这些持续的发展为长期氧气疗法解决方案（例如携带式氧气浓缩机）的未来市场扩张铺平了道路。

为什么要购买这份报告？

  • 富有洞察力的分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户细分、政府政策和社会经济因素、消费者偏好、行业和其他子区隔。
  • 竞争格局：了解世界主要企业采取的策略策略，并了解透过正确的策略渗透市场的潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力做出策略决策，以在动态环境中发现新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业有用且具有成本效益。

它有什么用？

产业和市场考量、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 2022年至2029年的实际资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略和市场占有率分析
  • 区域收益成长和预测分析，包括细分市场和国家
  • 公司简介（主要是策略、产品、财务资讯、主要动态等）

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程
  • 资料检验

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析

第五章携带式氧气浓缩机市场：副产品

  • 介绍
  • 连续流携带式氧气浓缩机
  • 脉衝流携带式氧气浓缩机

第六章携带式氧气浓缩机市场：依最终用户分类

  • 介绍
  • 居家照护环境
  • 空中救护车
  • 其他的

第七章携带式氧气浓缩机市场：依地区

  • 介绍
  • 北美洲
    • 副产品
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 副产品
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 副产品
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 副产品
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 副产品
    • 按最终用户
    • 按国家/地区

第八章竞争环境及分析

  • 主要企业及策略分析
  • 新兴企业和市场盈利
  • 併购/协议/合作
  • 竞争对手仪表板

第九章 公司简介

  • Precision Medical Inc.
  • Nidek Medical Products Inc.
  • Philips Healthcare
  • Drive DeVilbiss international
  • Invacare Corporation
  • Chart Industries
  • Inogen Inc
  • Summit Oxygen international
  • Nareena Lifesciences Private Limited
  • Anand Medicaids
  • Hindustan Engineers
  • Global Medical Devices
  • EVOX, India
简介目录
Product Code: KSI061610973

The portable oxygen concentrator market is estimated to attain US$4.869 billion by 2030, growing at a CAGR of 11.23%, from US$2.860 billion in 2025.

A portable oxygen concentrator is a device which features a small, lightweight, and silent design and offers patients a continuous supply of oxygen. Hence, they offer applicability across multiple sectors, which majorly includes utilization in homecare settings, ambulances, and aero-ambulances. The portable oxygen concentrator ensures a higher oxygen output and it also helps in increasing the survival rate of the critical patients.

The demand for portable oxygen concentrators in the global market is expected to witness a significant increase fuelled with the increasing older population across the world as they offers multiple benefits to the older population such as increasing the body's ability to inhale pure oxygen. With the increasing age of individuals, the risk of various types of respiratory or pulmonary diseases like chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and other type of lung diseases increase drastically.

The World Bank, in its global population report, stated that in 2024, the total population aged 65 years and above was recorded at 804.475 million. This marked a major growth from 2021, when the total population aged 65 and above was recorded at 754.681 million, and about 778.122 million in 2022.

Portable Oxygen Concentrator Market Drivers

  • Growing global cases of respiratory diseases is propelling the market expansion

The increasing global cases of pulmonary or respiratory diseases are among the key factors propelling the growth of the global portable oxygen concentrator market during the estimated timeline. The global cases of various types of respiratory and lung diseases like COPD, emphysema, and chronic bronchitis witnessed major growth across the globe. The cases of respiratory diseases witnessed a growth majorly caused by various factors like pollution, age, and lifestyle of the individuals.

The American Lung Association in its report stated that in the USA, about 11.7 million adults are affected by COPD or chronic obstructive pulmonary disease. Similarly, the Centers for Disease Control and Prevention of the USA stated that in the nation, about 4.3% of the total population of the nation, in 2023, were diagnosed with COPD, emphysema, or chronic bronchitis. The agency further stated that in the nation, chronic lower respiratory disease, which includes asthma caused about 147,382 deaths, which is equal to about 44.2 deaths per 100,000 population of the nation. The agency stated that emphysema and bronchitis diseases in 2023 caused about 7,905 and 358 deaths respectively, whereas the other chronic lower respiratory diseases which excludes asthma caused 135,517 deaths. In the nation, asthma caused about 3,602 deaths, which is equivalent to 1.1 deaths per 100,000 population.

Similarly, Statistics Canada, in its report stated that the cases of deaths caused by various types of respiratory diseases also witnessed a constant growth. The agency stated that in 2021, about 311,640 deaths in the nation were caused by respiratory disease, which increased to 334,081 in 2022. Likewise, the same source also specified that the deaths caused by chronic lower respiratory diseases increased in the nation from 11,018 deaths in 2021 to 12,462 deaths in 2022. In 2023, the total number of deaths caused by chronic lower respiratory diseases was recorded at 12,994.

The cases of respiratory diseases in India also witnessed significant growth during the past few years. The major factor boosting the cases of pulmonary and respiratory diseases in the Indian market is the increasing pollution and rising consumption of tobacco. The National Institute of Health of the Indian Government in its report stated that air pollution in the nation caused about 25.6% of the total cases of chronic obstructive pulmonary disease or COPD, and tobacco is responsible for about 16.5% of the cases. The Indian Journal of Public Health in its report stated that in India, the total cases of COPD were estimated at 37.8 million. which is about 17.8% of the total global cases. The journal also stated that the cases of COPD in the nation contribute to about 27.3% of the global deaths, caused by COPD.

Furthermore, the Scottish Public Health Observatory under its Public Health Information for Scotland platform stated that in Scotland, the cases of COPD witnessed a major growth from 2018, to 2023. The agency further stated that in the nation, the total deaths caused by COPD in Scotland was recorded at 2.2% for males, whereas the death rate caused by COPD for women was recorded at 2.4%.

Portable Oxygen Concentrator Market Geographical Outlook:

  • The North America is expected to dominate the market in the coming years

Portable oxygen concentrators form an integral part of long-term oxygen therapy as they reduce the gap between oxygen solutions availability and their usage for patients suffering from chronic obstructive pulmonary disease or lung cancer. Tackling such disease has become a major concern in the United States with various investments and initiatives being undertaken to bolster the development of required solutions.

According to the Lung Cancer Research Foundation, nearly 654,620 Americans have been diagnosed with lung cancer at some point in their lives, and the annual death count reaches up to 125,070 annually. Likewise, according to the "State of Lung Cancer Report 2023' issued by the American Lung Association, nearly 238,000 people were diagnosed with lung cancer in 2023 which represented an increase of 1000 new cases in comparison to 2022.

Moreover, old age people are more prone to respiratory and lung disease and with the constant growth in the geriatric population of the United States, the probability of people getting diagnosed with some form of respiratory disease is also expected to grow. According to the Population Reference Bureau, by 2050 population aged 65 years and above will reach up to 82 million thereby signifying a remarkable growth of 47% over the population recorded in 2022. Hence the same source further specified that the percentage share of old age people will increase from 17% to 23% in the given period.

However, the ongoing developments in lung cancer treatment over the years have reduced the prevalence rate thereby providing a major scope for the usage of portable oxygen concentrators. As per the American Lung Cancer Association, the survival rate of Americans has improved by 26% over the past five years, with the federal government working on opportunities to increase cancer screening and increase access to required oxygen solutions for patients.

Moreover, major players operating in portable oxygen concentrators have established their base in the US market as they aim to optimize the growing opportunity. For instance, as per the 2023 annual report of Inogen Inc. of the total company revenue of US$315.600 million, the United States contributed US$226.3 million thereby constituting nearly 70% of the total revenue.

Furthermore, the company is also investing in new product launches with the recent development being made in October 2024, where the company introduced the "Rove 4" portable oxygen concentrator that is ideal for home care settings in the US market, Additionally, the company, in August 2023, showcased" Rove 6" portable oxygen concentrator in the US. Hence, such ongoing developments followed by constant efforts being made to reduce the mortality rate of lung cancer patients have paved the way for the future market expansion of long-term oxygen therapy solutions such as portable oxygen concentrators.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2029
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Portable Oxygen Concentrator Market is analyzed into the following segments:

By Product

  • Continuous Flow Portable Oxygen concentrator
  • Pulse Flow Portable Oxygen Concentrator

By End-User

  • Homecare Setting
  • Air Ambulance
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Taiwan
  • Indonesia
  • Others

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholders

2. Research Methodology

  • 2.1. Research Design
  • 2.2. Research Process
  • 2.3. Data Validation

3. Executive Summary

  • 3.1. Key Findings
  • 3.2. Analyst View

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Supplier
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Portable Oxygen Concentrator Market By Product

  • 5.1. Introduction
  • 5.2. Continuous Flow Portable Oxygen Concentrator
  • 5.3. Pulse Flow Portable Oxygen Concentrator

6. Portable Oxygen Concentrator Market By End-User

  • 6.1. Introduction
  • 6.2. Homecare Setting
  • 6.3. Air Ambulance
  • 6.4. Others

7. Portable Oxygen Concentrator Market By Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Product
    • 7.2.2. By End-User
    • 7.2.3. By Country
      • 7.2.3.1. United States
      • 7.2.3.2. Canada
      • 7.2.3.3. Mexico
  • 7.3. South America
    • 7.3.1. By Product
    • 7.3.2. By End-User
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
      • 7.3.3.2. Argentina
      • 7.3.3.3. Others
  • 7.4. Europe
    • 7.4.1. By Product
    • 7.4.2. By End-User
    • 7.4.3. By Country
      • 7.4.3.1. United Kingdom
      • 7.4.3.2. Germany
      • 7.4.3.3. France
      • 7.4.3.4. Italy
      • 7.4.3.5. Spain
      • 7.4.3.6. Others
  • 7.5. Middle East and Africa
    • 7.5.1. By Product
    • 7.5.2. By End-User
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
      • 7.5.3.2. UAE
      • 7.5.3.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. By Product
    • 7.6.2. By End-User
    • 7.6.3. By Country
      • 7.6.3.1. China
      • 7.6.3.2. Japan
      • 7.6.3.3. South Korea
      • 7.6.3.4. India
      • 7.6.3.5. Indonesia
      • 7.6.3.6. Thailand
      • 7.6.3.7. Taiwan
      • 7.6.3.8. Others

8. Competitive Environment and Analysis

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. Company Profiles

  • 9.1. Precision Medical Inc.
  • 9.2. Nidek Medical Products Inc.
  • 9.3. Philips Healthcare
  • 9.4. Drive DeVilbiss international
  • 9.5. Invacare Corporation
  • 9.6. Chart Industries
  • 9.7. Inogen Inc
  • 9.8. Summit Oxygen international
  • 9.9. Nareena Lifesciences Private Limited
  • 9.10. Anand Medicaids
  • 9.11. Hindustan Engineers
  • 9.12. Global Medical Devices
  • 9.13. EVOX, India